ImpairedEPIGERNCT02900391
Urgent Care for the Elderly: Impairment and Home Care Services
An observational study of Impaired, run by European Georges Pompidou Hospital.
Trial summary
Elderly population is increasing quickly and their need for health care ressources through emergency care is also growing. While these patients are ageing physical impairment often happens along the way. Read more about this study
- Who is it for?
- Ages 80 years and older
- Conditions the study is for
- Impaired
- How many people
- 3,200 participants
- Where
- No sites listed yet
- Study dates
- Mar 2016to Mar 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 80 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: All patients aged 80 and over visiting the ED, taking in charge by SMUR (medical EMS) or calling SAMU (medical call center) during 24 hours
Who may be able to join
- patients aged 80 and over
Who cannot join
- aged<80 years old
About this study
Elderly population is increasing quickly and their need for health care ressources through emergency care is also growing. While these patients are ageing physical impairment often happens along the way. Apart from senior homes, different types and levels of home care services have been developped in order to overcome or to adapt to these situations.
Our goals are:
- to assess mortality rate depending on home care services level for the elderly population consulting in the ED or being taken in charge by the Emergency Medical System in France.
- to describe this population in terms of autonomy, impairment and home care services
- Conditions
- Impaired
What is being measured
The primary outcome is the main question the study is designed to answer.
Mortality rate at hospital discharge
Mortality rate at hospital discharge
Measured: At hospital discharge or 30 days at most
Secondary outcomes (3)
Admission rate
Admission in a medical, surgical or psychiatric unit are considered
Measured: Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
Level of home care services
Different items in a questionnaire are asked to the patient or family concerning weekly home care services use for patient usually (which type and how often)
Measured: Questionnaires given the day of the inclusion
Level of health care ressources
Lab investigations, radiology, surgery, treatment administered
Measured: During the ED visit (less than 24 hours), the day of the inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2016 (estimated)
- Study startMar 2016
- Primary completionMar 2016
- Study completionMar 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ImpairedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 3,200 participants (actual)
Sponsor and investigators
- Lead sponsor
- European Georges Pompidou Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anne-Laure Feral-Pierssens, European Georges Pompidou Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02900391
- Sponsor's protocol ID
- EPIGER
- Acronym
- EPIGER
- Status last verified
- Sep 2016
- First submitted
- 1 Sep 2016
- Last updated
- 14 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Feral-Pierssens AL, Toury G, Sehimi F, Peschanski N, Laribi S, Carpentier A, Kraif M, Carbonnier C, Duchateau FX, Freund Y, Juvin P; EPIGER IRU-SFMU study group. Emergency department outcome of elderly patients assisted by professional home services, the EPIGER study. BMC Geriatr. 2020 Sep 21;20(1):355. doi: 10.1186/s12877-020-01742-1.
PubMed 32957921
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Urgent Care for the Elderly: Impairment and Home Care Services
- ClinicalTrials.gov ID
- NCT02900391
- Acronym / sponsor ID
- EPIGER / EPIGER
- Conditions
- Impaired
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,200 participants (actual)
- Lead sponsor
- European Georges Pompidou HospitalUniversity, hospital or other
- Study start
- Mar 2016
- Primary completion
- Mar 2016 (actual)
- Study completion
- Mar 2016 (actual)
- First posted
- 14 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Elderly population is increasing quickly and their need for health care ressources through emergency care is also growing. While these patients are ageing physical impairment often happens along the way. Apart from senior homes, different types and levels of home care services have been developped in order to overcome or to adapt to these situations.
Our goals are:
- to assess mortality rate depending on home care services level for the elderly population consulting in the ED or being taken in charge by the Emergency Medical System in France.
- to describe this population in terms of autonomy, impairment and home care services
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 80 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- All patients aged 80 and over visiting the ED, taking in charge by SMUR (medical EMS) or calling SAMU (medical call center) during 24 hours
Key inclusion criteria (1 listed)
- patients aged 80 and over
Key exclusion criteria (1 listed)
- aged<80 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mortality rate at hospital discharge
Time frame: At hospital discharge or 30 days at most
Mortality rate at hospital discharge
3 secondary outcomes
Admission rate
Time frame: Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
Level of home care services
Time frame: Questionnaires given the day of the inclusion
Level of health care ressources
Time frame: During the ED visit (less than 24 hours), the day of the inclusion
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2016.
- Derived from this study: PubMed 32957921Feral-Pierssens AL, Toury G, Sehimi F, Peschanski N, Laribi S, Carpentier A, Kraif M, Carbonnier C, Duchateau FX, Freund Y, Juvin P; EPIGER IRU-SFMU study group. Emergency department outcome of elderly patients assisted by professional home services, the EPIGER study. BMC Geriatr. 2020 Sep 21;20(1):355. doi: 10.1186/s12877-020-01742-1.
- Individual participant dataSharing planned: No
Related trials for Impaired
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Focal Seizure, Epilepsy
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Recruiting
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
Alzheimer Disease, Dementia
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Not yet recruitingPhase 1
A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)
Healthy, Renal Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Impaired, run by European Georges Pompidou Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mortality rate at hospital discharge (time frame: At hospital discharge or 30 days at most). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02900391, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2016.